Clostridioides difficile infection (CDI) & Gut microbiota

How gut microbiome suppresses C. difficile incompletely understood

Clostridioides difficile is a major cause of antibiotic-associated diarrhea. Although the gut microbiome suppresses C. difficile, the mechanisms are incompletely understood
Tian et al. 2025 Cell Host & Microbe 33: 373-387

How is the proliferation of Clostridioides (Clostridium) difficile regulated by the gut microbiota?

The gut microbiota plays a critically important role in Clostridioides difficile infection (CDI). A healthy microbiota is naturally resistant to colonization by Clostridioides (Clostridium) difficile. However, when dysbiosis occurs, often due to exposure to antimicrobials, it allows C. difficile spores to germinate and produce toxins. This can lead to symptoms that vary from mild diarrhea to severe colitis and even death.
Chilton et al. 2026 Nat Rev Microbiol 24: 215-232

Competition for nutrients, rather than bile-acid transformation alone, can be a decisive mechanism of resistance to C. difficile colonization
Tian et al. 2025 Cell Host & Microbe 33: 373-387

A disruption of the gut microbiome favors the colonization, proliferation, and production of Clostridioides (Clostridium) difficile toxins, which damage the intestinal epithelial layer.
Li & Saavedra 2025 mBio 16: e03562-24

Clostridioides difficile infection (CDI), particularly when recurrent, is linked to a reduction in microbial diversity and a decrease in microbe-derived secondary bile acids. These acids play a crucial role in inhibiting the germination and growth of Clostridioides (Clostridium) difficile.
McGovern et al. 2021 cid 2021: 72

The inflammation induced by Clostridioides (Clostridium) difficile toxins activity alters the gut microbiota, excluding members from the genus Bacteroides that are able to utilize the same essential nutrients released from collagen degradation.
Fletcher et al. 2021

By examining a single stool sample, patients at high risk of Clostridioides difficile infection (CDI) (recurrent) can be identified with an accuracy of >90% either before the start of antibiotic administration or 14 days after the end of antibiotic administration.
Lee et al. 2020e Inflammatory Bowel Diseases 26: 1748–1758

Clostridioides difficile infection (CDI) being treated by gut microbiota modulation has a profound dysbiosis
Wargo 2020

Antibiotics alter the Gut microbiota and decrease resistance to Clostridioides (formerly Clostridium) difficile colonization. Antibiotic treatment is associated with alterations in the gut metabolome, specifically, with increases in levels of nutrients that Clostridioides (formerly Clostridium) difficile can utilize for growth in vitro
Fletcher et al. 2018 mSphere 3(2): e00089-18

Summary

• Disruption of the gut microbiome, known as dysbiosis, promotes the colonization and toxin production of Clostridioides difficile, damaging the intestinal lining


• Inflammation from C. difficile toxins alters gut microbiota, excluding Bacteroides that utilize nutrients from collagen degradation


• High-risk patients for C. difficile infection can be identified with >90% accuracy from a stool sample before or after antibiotic treatment


• Gut microbiota modulation is a treatment for C. difficile infection, which is associated with profound dysbiosis


• Antibiotics alter gut microbiota, reducing resistance to C. difficile colonization and increasing nutrient levels that support its growth

see also:
Cephalosporins & Clostridioides (Clostridium) difficile
Clostridioides difficile infection (CDI) & Dysbiosis
Clostridioides difficile infection (CDI) & Pathogenicity / Pathology
Fecal Microbiota Transplantation (FMT) & Clostridioides difficile infection (CDI) (recurrent)